Myasthenia gravis (MG) in children and adolescents to age 18 -- juvenile MG -- includes clinically significant developmental ...

HOUSE, PA — Johnson & Johnson (NYSE: JNJ) has unveiled new data demonstrating the efficacy of IMAAVY™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis (gMG). Presented at the ...

Thymoma is strongly associated with myasthenia gravis (MG), particularly at the onset of the disease 1 1. Zielinski M. Management of myasthenic patients with thymoma. Thorac Surg Clin 2011;21:47-57. .